RxDoctor Payments Data

David Lee, MD

Urology · Orange, CANPI 1730128232

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (35.2%), education and food and beverage — rather than concentrated in one kind of arrangement. Intuitive Surgical accounts for 87.9% of it on its own, with 10 other manufacturers making up the rest. 2025 is the largest year on record at $7,155, 5.2 times the $1,364 reported in 2019.

$19,874in general payments, 2019–2025

Across 92 payments — averaging $216.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$17K
  • MML US, Inc.$2K
  • Axogen$309
  • C. R. Bard, Inc. & Subsidiaries$142
  • Metuchen Pharmaceuticals$97
  • Stryker$87
  • plus $125 from 5 others
$23,800in research payments, 2019–2025

Across 5 payments — averaging $4760.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Ferring International Pharmascience Center US$20K
  • Ferring Pharmaceuticals AS$4K

What the payments were for

  • Speaking & faculty fees$3,00015%
  • Travel & lodging$6,99835%
  • Food & beverage$3,20116%
  • Education$6,50033%
  • Gifts$1751%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Intuitive Surgical62$17,464
MML US, Inc.13$1,649
Axogen3$309
C. R. Bard, Inc. & Subsidiaries1$142
Metuchen Pharmaceuticals6$97
Stryker1$87
Procept Biorobotics Corporation1$34
Caris MPI, Inc.1$33
Astellas Pharma US Inc2$25
Abbott1$20
Koelis Inc.1$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$19,874 in reported general payments places this provider in the 85th percentile of 1,324 urology providers in California.

See all urology providers in California →

Medicare billing

Part B allowed, 2024
$194,778
Medicare patients
367
Services billed
2,074

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Tamsulosin Hcl52$809
Finasteride27$349

Paid to pharmacies, not to this prescriber.

Other urology in Orange

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →